1. Figure Correction: The Effect of a Cellular-Enabled Glucose Meter on Glucose Control for Patients With Diabetes: Prospective Pre-Post Study
- Author
-
Tong Xu, Stefanie L. Painter, Jennifer B. Bollyky, Brian Knox, and Stephanie T. Melton
- Subjects
medicine.medical_specialty ,lcsh:RC648-665 ,Glucose control ,business.industry ,Endocrinology, Diabetes and Metabolism ,Glucose meter ,Biomedical Engineering ,Health Informatics ,medicine.disease ,Corrigenda and Addenda ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,Computer Science Applications ,Endocrinology ,Health Information Management ,Internal medicine ,Diabetes mellitus ,medicine ,business - Abstract
Diabetes is a global epidemic affecting approximately 30 million people in the United States. The World Health Organization recommends using technology and telecommunications to improve health care delivery and disease management. The Livongo for Diabetes Program offers a remote monitoring technology with Certified Diabetes Educator outreach.The purpose of this study was to examine health outcomes measured by changes in HbAThe impact of the Livongo for Diabetes program on hemoglobin AA total of 86 adults were enrolled into the Livongo for Diabetes program, with 49% (42/86) female, an average age of 50 (SD 15) years, 56% (48/86) with type 2 diabetes mellitus, and 69% (59/86) with insulin use. The mean HbAParticipants provided with a cellular-enabled blood glucose meter with real-time feedback and access to coaching from a certified diabetes educator in an outpatient clinical setting experienced improved mean glucose values and fewer episodes of hypoglycemia relative to the start of the program.
- Published
- 2020